Research

Hormonal

Combining GLP-1 receptor agonists (Liraglutide or Exenatide) with Metformin significantly improves pregnancy rates and endometrial receptivity compared to Metformin monotherapy in women with PCOS undergoing IVF.

If you have PCOS, are overweight, and are struggling with infertility despite trying standard treatments like Clomiphene, ask your doctor about adding Liraglutide to your Metformin regimen before starting IVF. One study showed this combination significantly improved pregnancy rates per embryo transfer compared to Metformin alone. Note that these drugs are not approved for use during pregnancy, so a washout period is required.

ModerateSupportsMEDIUM confidence
After 1 year of follow-up, pregnancy was achieved in 69.2% of women in the combination arm and in 35.4% of women in the monotherapy arm. The PR per ET was significantly higher (85.7%) in the participants in the combination arm compared to 28.6% in the other group (p = 0.03).
Georgios S. Papaetis et al. · Advances in Clinical and Experimental Medicine · 2022

Why this rating

Based on a single small trial (n=27 analyzed) cited in the review; requires larger validation.

Source

GLP-1 receptor agonists, polycystic ovary syndrome and reproductive dysfunction: Current research and future horizons

Georgios S. Papaetis et al. · Advances in Clinical and Experimental Medicine · 2022

DOI 10.17219/acem/151695

narrative_reviewCited 35×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →